|
SLP | Simulations Plus, Inc. |
| Services-Computer Integrated Systems Design |
| Book value per $ invested | $ 0.38 |
| Leverage | 9.11% |
| Market Cap | $ 367.0m |
| PE | 49.78 |
| Dividend Yield | 0.00% |
| Profit | $ 7.4m |
| Margin | 8.89% |
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.